Elena Viboch

Elena Viboch is a seasoned investment professional currently serving as a Partner at General Catalyst since January 2022. Previously, Elena held the position of Investment Director at SoftBank Investment Advisers from February 2019 to January 2022, managing investments in companies such as Deep Genomics and insitro. Elena's earlier roles include Director of Corporate Development at NanoString Technologies, Director of Business Development & Operations at Carmot Therapeutics, and Senior Manager of Corporate Development & Strategy at FLX Bio, Inc. Additionally, Elena worked in corporate development at Jazz Pharmaceuticals and served as an Investor at Kearny Venture Partners. Early in the career, Elena was a Consultant at Putnam Associates, specializing in strategy for the pharmaceutical and biotechnology sectors. Elena holds an MBA from Harvard Business School, a BA from Swarthmore College, and an MS in Biotechnology from The Johns Hopkins University.